Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Wolpin B.,,"Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer",2009,Journal of Clinical Oncology,164,10.1200/JCO.2008.17.9945,Canada,Article,Montreal,0,Journal,2-s2.0-58249092146
Phoenix K.,,Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model,2009,Breast Cancer Research and Treatment,134,10.1007/s10549-008-9916-5,United States,Article,Farmington,0,Journal,2-s2.0-58149156184
Cox M.,,Insulin receptor expression by human prostate cancers,2009,Prostate,150,10.1002/pros.20852,Canada,Article,Vancouver,1,Journal,2-s2.0-58149339692
Fuchs C.,,"Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: Results from intergroup trial N9741",2008,Clinical Cancer Research,44,10.1158/1078-0432.CCR-08-0480,United States;United States,Article,Boston;Boston,1,Journal,2-s2.0-58149359607
Law J.H.,,Phosphorylated insulin-like growth factor-I/insulin receptor is present in all breast cancer subtypes and is related to poor survival,2008,Cancer Research,299,10.1158/0008-5472.CAN-08-2755,Canada,Article,Vancouver,1,Journal,2-s2.0-57749089652
Hede K.,,Doctors seek to prevent breast cancer recurrence by lowering insulin levels,2008,Journal of the National Cancer Institute,24,10.1093/jnci/djn119,,Note,,1,Journal,2-s2.0-43149106499
Toyoshima Y.,,The role of insulin receptor signaling in zebrafish embryogenesis,2008,Endocrinology,45,10.1210/en.2008-0329,United States,Article,New York,1,Journal,2-s2.0-56749086535
So A.,,Insulin-like growth factor binding protein-2 is a novel therapeutic target associated with breast cancer,2008,Clinical Cancer Research,57,10.1158/1078-0432.CCR-08-0408,Canada,Article,Vancouver,1,Journal,2-s2.0-56749144704
Ma J.,,"Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis",2008,The Lancet Oncology,302,10.1016/S1470-2045(08)70235-3,United States;United States,Article,Philadelphia;Boston,0,Journal,2-s2.0-54349083481
Shang Y.,,Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake,2008,Molecular Cancer Therapeutics,31,10.1158/1535-7163.MCT-07-2401,United States,Article,San Francisco,1,Journal,2-s2.0-54049118086
Buck E.,,Feedback mechanisms promote cooperativity for small molecule inhibitors of epidermal and insulin-like growth factor receptors,2008,Cancer Research,168,10.1158/0008-5472.CAN-07-6720,United States,Article,Farmingdale,1,Journal,2-s2.0-54249117292
Chitnis M.M.,,The type 1 insulin-like growth factor receptor pathway,2008,Clinical Cancer Research,309,10.1158/1078-0432.CCR-07-4879,United Kingdom;United Kingdom,Review,Oxford;Oxford,1,Journal,2-s2.0-56749110996
Creighton C.,,Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis,2008,Journal of Clinical Oncology,193,10.1200/JCO.2007.13.4429,United States,Article,Houston,0,Journal,2-s2.0-51649091930
Reeves S.G.,,IGF1 is a modifier of disease risk in hereditary non-polyposis colorectal cancer,2008,International Journal of Cancer,23,10.1002/ijc.23668,Australia,Article,Newcastle,1,Journal,2-s2.0-49749090157
Lacy M.Q.,,"Phase I, pharmacokinetic and pharmacodynamic study of the anti-insulinlike growth factor type 1 receptor monoclonal antibody CP-751,871 in patients with multiple myeloma",2008,Journal of Clinical Oncology,140,10.1200/JCO.2007.15.9319,United States,Article,New York,0,Journal,2-s2.0-49249125421
Blagosklonny M.,,"Cancer and aging: More puzzles, more promises?",2008,Cell Cycle,33,10.4161/cc.7.17.6626,United States,Review,Albany,1,Journal,2-s2.0-50849124484
Anisimov V.,,Metformin slows down aging and extends life span of female SHR mice,2008,Cell Cycle,218,10.4161/cc.7.17.6625,Russian Federation,Article,Saint Petersburg (ex Leningrad),1,Journal,2-s2.0-50849113473
Narkar V.,,AMPK and PPARδ Agonists Are Exercise Mimetics,2008,Cell,837,10.1016/j.cell.2008.06.051,United States,Article,San Diego,1,Journal,2-s2.0-48449094498
Cornelissen B.,,The level of insulin growth factor-1 receptor expression is directly correlated with the tumor uptake of <sup>111</sup>In-IGF-1(E3R) in vivo and the clonogenic survival of breast cancer cells exposed in vitro to trastuzumab (Herceptin),2008,Nuclear Medicine and Biology,31,10.1016/j.nucmedbio.2008.05.010,Canada,Article,Toronto,0,Journal,2-s2.0-48249128676
Zhu Z.,,"Effect of nonmotorized wheel running on mammary carcinogenesis: Circulating biomarkers, cellular processes, and molecular mechanisms in rats",2008,Cancer Epidemiology Biomarkers and Prevention,32,10.1158/1055-9965.EPI-08-0175,United States,Article,Fort Collins,1,Journal,2-s2.0-54049091251
Martins A.,,A pivotal role for heat shock protein 90 in Ewing sarcoma resistance to anti-insulin-like growth factor 1 receptor treatment: In vitro and in vivo study,2008,Cancer Research,62,10.1158/0008-5472.CAN-07-3074,Spain,Article,Salamanca,1,Journal,2-s2.0-51049098720
Gotlieb W.,,In vitro metformin anti-neoplastic activity in epithelial ovarian cancer,2008,Gynecologic Oncology,205,10.1016/j.ygyno.2008.04.008,Canada;Canada,Article,Montreal;Montreal,0,Journal,2-s2.0-47249088612
Locke J.,,Androgen Levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer,2008,Cancer Research,552,10.1158/0008-5472.CAN-07-5997,Canada,Article,Vancouver,1,Journal,2-s2.0-51049098138
Zhu W.,,IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis,2008,Nature,163,10.1038/nature07027,Japan,Article,Chiba,1,Journal,2-s2.0-47549113841
Zimmermann K.,,Balancing oral exposure with Cyp3A4 inhibition in benzimidazole-based IGF-IR inhibitors,2008,Bioorganic and Medicinal Chemistry Letters,20,10.1016/j.bmcl.2008.05.104,United States,Article,New York,0,Journal,2-s2.0-47149115273
Lisztwan J.,,The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer,2008,Breast Cancer Research,41,10.1186/bcr2113,Switzerland,Article,Basel,1,Journal,2-s2.0-56749118600
Inagaki T.,,Inhibition of Growth Hormone Signaling by the Fasting-Induced Hormone FGF21,2008,Cell Metabolism,260,10.1016/j.cmet.2008.05.006,United States,Article,Dallas,1,Journal,2-s2.0-45649085226
Osborne R.,,Commercial interest waxes for IGF-1 blockers,2008,Nature Biotechnology,14,10.1038/nbt0708-719,,Note,,0,Journal,2-s2.0-46949107513
Jiang W.,,"Dietary energy restriction modulates the activity of AMP-activated protein kinase, Akt, and mammalian target of rapamycin in mammary carcinomas, mammary gland, and liver",2008,Cancer Research,127,10.1158/0008-5472.CAN-07-6721,United States,Article,Fort Collins,1,Journal,2-s2.0-48549091164
Guix M.,,Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins,2008,Journal of Clinical Investigation,453,10.1172/JC134588,United States,Article,Nashville,0,Journal,2-s2.0-46749156706
Kroemer G.,,Tumor Cell Metabolism: Cancer's Achilles' Heel,2008,Cancer Cell,1379,10.1016/j.ccr.2008.05.005,France;France;France,Review,Saint-Aubin;Villejuif;Paris,1,Journal,2-s2.0-44449147036
Sahra I.B.,,The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level,2008,Oncogene,637,10.1038/sj.onc.1211024,France;France,Article,Nice;Paris,1,Journal,2-s2.0-44849099894
Moore T.,,Dietary energy balance modulates signaling through the Akt/mammalian target of rapamycin pathways in multiple epithelial tissues,2008,Cancer Prevention Research,116,10.1158/1940-6207.CAPR-08-0022,United States;United States,Article,Smithville;Austin,1,Journal,2-s2.0-56549109059
Huang X.,,Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice,2008,Biochemical Journal,292,10.1042/BJ20080557,United Kingdom,Article,Dundee,0,Journal,2-s2.0-44449103256
Borger D.,,AMP-activated protein kinase is essential for survival in chronic hypoxia,2008,Biochemical and Biophysical Research Communications,20,10.1016/j.bbrc.2008.03.056,United States,Article,Boston,0,Journal,2-s2.0-42249091173
Bouatia-Naji N.,,A polymorphism within the G6PC2 gene is associated with fasting plasma glucose levels,2008,Science,177,10.1126/science.1156849,France,Article,Lille,0,Journal,2-s2.0-44449091627
Hardie D.,,AMPK and Raptor: Matching Cell Growth to Energy Supply,2008,Molecular Cell,93,10.1016/j.molcel.2008.04.012,United Kingdom,Short Survey,Dundee,1,Journal,2-s2.0-42949130656
Cardoso H.,,Secular changes in body height and weight of Portuguese boys over one century,2008,American Journal of Human Biology,24,10.1002/ajhb.20710,Portugal,Article,Coimbra,0,Journal,2-s2.0-43449117535
Kling J.,,Inhaled insulin's last gasp?,2008,Nature Biotechnology,40,10.1038/nbt0508-479,,Note,,0,Journal,2-s2.0-43449134352
Folsom A.,,Variation in TCF7L2 and increased risk of colon cancer,2008,Diabetes Care,52,10.2337/dc07-2131,United States,Article,Minneapolis,1,Journal,2-s2.0-48649110179
Gwinn D.M.,,AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint,2008,Molecular Cell,2182,10.1016/j.molcel.2008.03.003,United States,Article,San Diego,1,Journal,2-s2.0-42949139481
Eccles S.A.,,"NVP-AUY922: A novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis",2008,Cancer Research,343,10.1158/0008-5472.CAN-07-5256,United Kingdom,Article,London,1,Journal,2-s2.0-42349084306
Christofk H.,,The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth,2008,Nature,1778,10.1038/nature06734,United States,Article,Boston,0,Journal,2-s2.0-40749163248
Vasilcanu R.,,Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: Potential mechanistic involvement of Mdm2 and β-arrestin1,2008,Oncogene,59,10.1038/sj.onc.1210797,Sweden,Article,Stockholm,0,Journal,2-s2.0-40449095393
Suh Y.,,Functionally significant insulin-like growth factor I receptor mutations in centenarians,2008,Proceedings of the National Academy of Sciences of the United States of America,483,10.1073/pnas.0705467105,United States,Article,New York,1,Journal,2-s2.0-42149141146
Mulvihill M.J.,,"Novel 2-phenylquinolin-7-yl-derived imidazo[1,5-a]pyrazines as potent insulin-like growth factor-I receptor (IGF-IR) inhibitors",2008,Bioorganic and Medicinal Chemistry,59,10.1016/j.bmc.2007.10.061,United States,Article,Farmingdale,0,Journal,2-s2.0-38849133610
Frasca F.,,The role of insulin receptors and IGF-I receptors in cancer and other diseases,2008,Archives of Physiology and Biochemistry,281,10.1080/13813450801969715,Italy,Review,Catania,0,Journal,2-s2.0-47349101284
Teleman A.,,Nutritional Control of Protein Biosynthetic Capacity by Insulin via Myc in Drosophila,2008,Cell Metabolism,173,10.1016/j.cmet.2007.11.010,Germany,Article,Heidelberg,1,Journal,2-s2.0-37449029143
DeBerardinis R.,,The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation,2008,Cell Metabolism,2284,10.1016/j.cmet.2007.10.002,United States;United States,Review,Philadelphia;Philadelphia,1,Journal,2-s2.0-37449024702
Diorio C.,,Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels,2008,Cancer Epidemiology Biomarkers and Prevention,49,10.1158/1055-9965.EPI-07-2500,Canada;Canada;Canada;Canada,Article,Quebec;Quebec;Quebec;Montreal,1,Journal,2-s2.0-42149084438
De La Torre N.,,"Effects of weight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines, and insulin",2008,Journal of Clinical Endocrinology and Metabolism,97,10.1210/jc.2007-1370,Spain,Article,Madrid,1,Journal,2-s2.0-56749149074
Kaneda A.,,Enhanced sensitivity to IGF-II signaling links loss of imprinting of IGF2 to increased cell proliferation and tumor risk,2007,Proceedings of the National Academy of Sciences of the United States of America,84,10.1073/pnas.0710359105,United States,Article,Baltimore,1,Journal,2-s2.0-38049170553
Venkateswaran V.,,Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts,2007,Journal of the National Cancer Institute,130,10.1093/jnci/djm231,Canada,Article,Toronto,1,Journal,2-s2.0-38449105596
Dowling R.,,Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells,2007,Cancer Research,673,10.1158/0008-5472.CAN-07-2310,Canada,Article,Montreal,1,Journal,2-s2.0-36348950449
Plymate S.,,An antibody targeting the type I insulin-like growth factor receptor enhances the castration-induced response in androgen-dependent prostate cancer,2007,Clinical Cancer Research,52,10.1158/1078-0432.CCR-07-0648,United States;United States,Article,Seattle;Seattle,1,Journal,2-s2.0-35948940097
Lang S.,,"Targeting heat shock protein 90 in pancreatic cancer impairs insulin-like growth factor-I receptor signaling, disrupts an interleukin-6/signal-transducer and activator of transcription 3/hypoxia-inducible factor-1α autocrine loop, and reduces orthotopic tumor growth",2007,Clinical Cancer Research,121,10.1158/1078-0432.CCR-07-1104,Germany,Article,Regensburg,1,Journal,2-s2.0-35948977339
Haluska P.,,"Phase I dose escalation study of the anti-insulin-like growth factor-I receptor monoclonal antibody CP-751,871in patients with refractory solid tumors",2007,Clinical Cancer Research,219,10.1158/1078-0432.CCR-07-1118,United States,Article,Rochester,1,Journal,2-s2.0-35348815620
Rowinsky E.,,"IMC-A12, a human IgG<inf>1</inf> monoclonal antibody to the insulin-like growth factor I receptor",2007,Clinical Cancer Research,146,10.1158/1078-0432.CCR-07-1109,United States,Conference Paper,Somerville,1,Journal,2-s2.0-34848903049
Schernhammer E.S.,,Body shape throughout life and correlations with IGFs and GH,2007,Endocrine-Related Cancer,55,10.1677/ERC-06-0080,United States;United States;Austria,Article,Boston;Boston;Vienna,1,Journal,2-s2.0-35948970288
Giovannucci E.,,"Metabolic syndrome, hyperinsulinemia, and colon cancer: A review",2007,American Journal of Clinical Nutrition,362,10.1093/ajcn/86.3.836s,United States;United States,Conference Paper,Boston;Boston,1,Journal,2-s2.0-40349105880
Perks C.M.,,IGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells,2007,Oncogene,81,10.1038/sj.onc.1210397,United Kingdom,Article,Bristol,1,Journal,2-s2.0-35148818315
Adams T.D.,,Long-term mortality after gastric bypass surgery,2007,New England Journal of Medicine,1793,10.1056/NEJMoa066603,United States,Article,Salt Lake City,0,Journal,2-s2.0-34548075820
Sjöström L.,,Effects of bariatric surgery on mortality in Swedish obese subjects,2007,New England Journal of Medicine,3127,10.1056/NEJMoa066254,Sweden;Sweden;United States,Article,Gothenburg;Gothenburg;Baton Rouge,0,Journal,2-s2.0-34548090763
Arcaro A.,,Novel role for insulin as an autocrine growth factor for malignant brain tumour cells,2007,Biochemical Journal,38,10.1042/BJ20070309,Switzerland,Article,Zurich,0,Journal,2-s2.0-34547850673
Dong M.,,Quantitative mass spectrometry identifies insulin signaling targets in C. elegans,2007,Science,243,10.1126/science.1139952,United States,Article,San Diego,0,Journal,2-s2.0-34547810054
Hursting S.,,Energy balance and carcinogenesis: Underlying pathways and targets for intervention,2007,Current Cancer Drug Targets,43,10.2174/156800907781386623,United States;United States,Review,Smithville;Austin,0,Journal,2-s2.0-34547575781
Ji Q.,,"A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor-dependent tumor growth in vivo",2007,Molecular Cancer Therapeutics,120,10.1158/1535-7163.MCT-07-0070,United States,Article,Farmingdale,1,Journal,2-s2.0-34548058890
Buzzai M.,,Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth,2007,Cancer Research,688,10.1158/0008-5472.CAN-06-4447,United States,Article,Philadelphia,1,Journal,2-s2.0-34547114031
De Bono J.S.,,Potential applications for circulating tumor cells expressing the insulin-like growth factor-I receptor,2007,Clinical Cancer Research,162,10.1158/1078-0432.CCR-07-0268,United Kingdom;United Kingdom,Article,London;London,1,Journal,2-s2.0-34250783291
Del Rincon J.,,Growth hormone regulation of p85α expression and phosphoinositide 3-kinase activity in adipose tissue: Mechanism for growth hormone-mediated insulin resistance,2007,Diabetes,107,10.2337/db06-0299,United States,Article,Charlottesville,1,Journal,2-s2.0-34249656368
Pandini G.,,Functional responses and in vivo anti-tumour activity of h7C10: A humanised monoclonal antibody with neutralising activity against the insulin-like growth factor-1 (IGF-1) receptor and insulin/IGF-1 hybrid receptors,2007,European Journal of Cancer,61,10.1016/j.ejca.2007.03.009,Italy,Article,Catania,0,Journal,2-s2.0-34248170187
Benyoucef S.,,Characterization of insulin/IGF hybrid receptors: Contributions of the insulin receptor L2 and Fn1 domains and the alternatively spliced exon 11 sequence to ligand binding and receptor activation,2007,Biochemical Journal,139,10.1042/BJ20061709,United Kingdom,Article,Cambridge,0,Journal,2-s2.0-34247872895
Cosaceanu D.,,Ionizing radiation activates IGF-1R triggering a cytoprotective signaling by interfering with Ku-DNA binding and by modulating Ku86 expression via a p38 kinase-dependent mechanism,2007,Oncogene,80,10.1038/sj.onc.1210037,Sweden,Article,Stockholm,1,Journal,2-s2.0-34247140280
Miller A.,,Commentary: Implications of the frequent occurrence of occult carcinoma of the prostate,2007,International Journal of Epidemiology,7,10.1093/ije/dym052,Canada,Note,Toronto,1,Journal,2-s2.0-34447503765
Mehrian-Shai R.,,Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer,2007,Proceedings of the National Academy of Sciences of the United States of America,145,10.1073/pnas.0609139104,United States;United States,Article,Los Angeles;Los Angeles,1,Journal,2-s2.0-34248363956
Wan X.,,Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism,2007,Oncogene,606,10.1038/sj.onc.1209990,United States;United States,Article,Bethesda;Bethesda,1,Journal,2-s2.0-33947538050
Belfiore A.,,The role of insulin receptor isoforms and hybrid insulin/IGF-I receptors in human cancer,2007,Current Pharmaceutical Design,184,10.2174/138161207780249173,Italy,Review,Catanzaro,0,Journal,2-s2.0-34047174592
Tamimi R.M.,,"Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: A cross-sectional study",2007,Breast Cancer Research,59,10.1186/bcr1655,United States;United States,Article,Boston;Boston,1,Journal,2-s2.0-34248137067
Shevah O.,,Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: A preliminary report,2007,Growth Hormone and IGF Research,119,10.1016/j.ghir.2006.10.007,Israel,Article,Petah Tiqwa,0,Journal,2-s2.0-33847198926
Liang J.,,The energy sensing LKB1-AMPK pathway regulates p27<sup>kip1</sup> phosphorylation mediating the decision to enter autophagy or apoptosis,2007,Nature Cell Biology,634,10.1038/ncb1537,United States,Article,Houston,0,Journal,2-s2.0-33947250696
Samani A.,,The role of the IGF system in cancer growth and metastasis: Overview and recent insights,2007,Endocrine Reviews,779,10.1210/er.2006-0001,Canada;Canada,Review,Montreal;Hamilton,1,Journal,2-s2.0-33846874575
Johansson M.,,Implications for prostate cancer of insulin-like growth factor-I (IGF-I) genetic variation and circulating IGF-I levels,2007,Journal of Clinical Endocrinology and Metabolism,38,10.1210/jc.2007-0887,Sweden;Sweden,Article,Umea;Umea,1,Journal,2-s2.0-36849026070
Zhang H.,,Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin,2007,Cancer Research,121,10.1158/0008-5472.CAN-06-1712,United States,Article,Minneapolis,1,Journal,2-s2.0-33846458639
Sachdev D.,,Disrupting insulin-like growth factor signaling as a potential cancer therapy,2007,Molecular Cancer Therapeutics,296,10.1158/1535-7163.MCT-06-0080,United States,Review,Minneapolis,1,Journal,2-s2.0-33846807433
Shaw R.,,Glucose metabolism and cancer,2006,Current Opinion in Cell Biology,397,10.1016/j.ceb.2006.10.005,United States,Review,San Diego,0,Journal,2-s2.0-33750619348
Jenkins P.,,Cancers associated with acromegaly,2006,Neuroendocrinology,47,10.1159/000095531,United Kingdom,Conference Paper,London,0,Journal,2-s2.0-33750080457
Morton G.,,Central nervous system control of food intake and body weight,2006,Nature,1638,10.1038/nature05026,United States,Review,Seattle,0,Journal,2-s2.0-33748931457
Divisova J.,,The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth,2006,Breast Cancer Research and Treatment,72,10.1007/s10549-006-9168-1,United States,Article,Houston,0,Journal,2-s2.0-33746906218
Kurmasheva R.,,IGF-I mediated survival pathways in normal and malignant cells,2006,Biochimica et Biophysica Acta - Reviews on Cancer,154,10.1016/j.bbcan.2006.05.003,United States,Review,"Memphis TN,",0,Journal,2-s2.0-33746840153
Schernhammer E.,,"Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II",2006,Endocrine-Related Cancer,116,10.1677/erc.1.01149,United States;Austria,Article,Boston;Vienna,1,Journal,2-s2.0-33745069283
Cool B.,,Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome,2006,Cell Metabolism,604,10.1016/j.cmet.2006.05.005,United States,Article,Chicago,1,Journal,2-s2.0-33744514139
Carling D.,,LKB1: a sweet side to Peutz-Jeghers syndrome?,2006,Trends in Molecular Medicine,19,10.1016/j.molmed.2006.02.003,United Kingdom,Short Survey,London,0,Journal,2-s2.0-33646020680
Smith M.,,Insulin sensitivity during combined androgen blockade for prostate cancer,2006,Journal of Clinical Endocrinology and Metabolism,361,10.1210/jc.2005-2507,United States,Article,Boston,1,Journal,2-s2.0-33646029746
Freedland S.,,Are findings from studies of obesity and prostate cancer really in conflict?,2006,Cancer Causes and Control,82,10.1007/s10552-005-0378-3,United States,Article,Baltimore,0,Journal,2-s2.0-30544432478
O'Reilly K.,,mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt,2006,Cancer Research,1958,10.1158/0008-5472.CAN-05-2925,United States,Article,New York,1,Journal,2-s2.0-32944457518
Cheng I.,,Common genetic variation in IGF1 and prostate cancer risk in the multiethnic cohort,2006,Journal of the National Cancer Institute,99,10.1093/jnci/djj013,United States,Article,Los Angeles,1,Journal,2-s2.0-31544474588
Hardie D.,,Neither LKB1 Nor AMPK Are the Direct Targets of Metformin,2006,Gastroenterology,81,10.1053/j.gastro.2006.07.032,United Kingdom,Letter,Dundee,0,Journal,2-s2.0-33748118458
Haluska P.,,"In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417",2006,Cancer Research,160,10.1158/0008-5472.CAN-05-1107,United States,Article,Rochester,1,Journal,2-s2.0-31544464616
Bowker S.,,Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin,2006,Diabetes Care,717,10.2337/diacare.29.02.06.dc05-1558,Canada;Canada,Article,Edmonton;Edmonton,1,Journal,2-s2.0-33645766204
Shaw R.J.,,Medicine: The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin,2005,Science,1356,10.1126/science.1120781,United States;United States;United States,Article,San Diego;Boston;Boston,0,Journal,2-s2.0-28844433635
Rattan R.,,5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase,2005,Journal of Biological Chemistry,306,10.1074/jbc.M507443200,United States,Article,Charleston,1,Journal,2-s2.0-28244466264
Bernstein L.,,Lifetime recreational exercise activity and breast cancer risk among black women and white women,2005,Journal of the National Cancer Institute,144,10.1093/jnci/dji374,United States,Article,Los Angeles,1,Journal,2-s2.0-27944485762
Levitt R.,,PTEN-induction in U251 glioma cells decreases the expression of insulin-like growth factor binding protein-2,2005,Biochemical and Biophysical Research Communications,47,10.1016/j.bbrc.2005.08.229,Canada,Article,Montreal,0,Journal,2-s2.0-25644446718
Hofmann F.,,Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer,2005,Drug Discovery Today,128,10.1016/S1359-6446(05)03512-9,Switzerland,Review,Basel,0,Journal,2-s2.0-23044493251
Anisimov V.,,Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice,2005,Experimental Gerontology,323,10.1016/j.exger.2005.07.007,Russian Federation;Germany,Article,Saint Petersburg (ex Leningrad);Rostock,0,Journal,2-s2.0-24644475793
Majeed N.,,A germ line mutation that delays prostate cancer progression and prolongs survival in a murine prostate cancer model,2005,Oncogene,46,10.1038/sj.onc.1208572,Canada,Article,Montreal,1,Journal,2-s2.0-22744433507
Evans J.,,Metformin and reduced risk of cancer in diabetic patients,2005,British Medical Journal,1583,10.1136/bmj.38415.708634.F7,United Kingdom,Article,Dundee,1,Journal,2-s2.0-20444461067
Anisimov V.,,Metformin decelerates aging and development of mammary tumors in HER-2/neu transgenic mice,2005,Bulletin of Experimental Biology and Medicine,80,10.1007/s10517-005-0389-9,Russian Federation,Article,Saint Petersburg (ex Leningrad),0,Journal,2-s2.0-25444462729
Diorio C.,,"Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density",2005,Cancer Epidemiology Biomarkers and Prevention,116,10.1158/1055-9965.EPI-04-0706,Canada;Canada,Article,Quebec;Quebec,1,Journal,2-s2.0-20844457606
Cohen B.,,"Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751,871",2005,Clinical Cancer Research,314,10.1158/1078-0432.CCR-04-1070,United States,Article,New London,1,Journal,2-s2.0-20144386856
Ohsugi M.,,"Reduced expression of the insulin receptor in mouse insulinoma (MIN6) cells reveals multiple roles of insulin signaling in gene expression, proliferation, insulin content, and secretion",2005,Journal of Biological Chemistry,71,10.1074/jbc.M411727200,United States,Article,St. Louis,1,Journal,2-s2.0-14244269977
Jee S.,,Fasting serum glucose level and cancer risk in Korean men and women,2005,Journal of the American Medical Association,719,10.1001/jama.293.2.194,South Korea;United States,Article,Seoul;Baltimore,1,Journal,2-s2.0-11844259994
Kahn B.,,AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism,2005,Cell Metabolism,2065,10.1016/j.cmet.2004.12.003,United States,Review,Boston,1,Journal,2-s2.0-20844451123
De Meyts P.,,"Insulin and its receptor: Structure, function and evolution",2004,BioEssays,199,10.1002/bies.20151,Denmark,Review,Gentofte,0,Journal,2-s2.0-10844223660
Ahlgren M.,,Growth patterns and the risk of breast cancer in women,2004,New England Journal of Medicine,292,10.1056/NEJMoa040576,Denmark,Article,Copenhagen,0,Journal,2-s2.0-5344222810
Goya M.,,Growth inhibition of human prostate cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice by a ligand-specific antibody to human insulin-like growth factors,2004,Cancer Research,107,10.1158/0008-5472.CAN-04-0919,Japan,Article,Chuo-ku,1,Journal,2-s2.0-4344591505
Patel A.C.,,Effects of energy balance on cancer in genetically altered mice,2004,Journal of Nutrition,46,10.1093/jn/134.12.3394s,United States,Conference Paper,Bethesda,1,Journal,2-s2.0-9744274552
Pollak M.,,Insulin-like growth factors and neoplasia,2004,Nature Reviews Cancer,1110,10.1038/nrc1387,Canada,Review,Montreal,0,Journal,2-s2.0-3042781558
Calle E.,,"Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms",2004,Nature Reviews Cancer,2366,10.1038/nrc1408,United States,Review,Atlanta,0,Journal,2-s2.0-3543072186
Wu Y.,,Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors,2003,Cancer Research,171,,United States,Article,Bethesda,0,Journal,2-s2.0-0042090507
McCormack V.,,Fetal growth and subsequent risk of breast cancer: Results from long term follow up of Swedish cohort,2003,British Medical Journal,125,,United Kingdom,Article,London,0,Journal,2-s2.0-0037311014
Firth S.,,Cellular actions of the insulin-like growth factor binding proteins,2002,Endocrine Reviews,1326,10.1210/er.2001-0033,Australia,Review,Sydney,1,Journal,2-s2.0-0036905115
Kopchick J.J.,,"Growth hormone receptor antagonists: Discovery, development, and use in patients with acromegaly",2002,Endocrine Reviews,270,10.1210/er.2001-0022,United States,Article,Athens,1,Journal,2-s2.0-0036800303
Sandhu M.,,Self-reported birth weight and subsequent risk of colorectal cancer,2002,Cancer Epidemiology Biomarkers and Prevention,50,,United Kingdom,Article,Cambridge,0,Journal,2-s2.0-0036716902
Chan J.M.,,Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer,2002,Journal of the National Cancer Institute,380,10.1093/jnci/94.14.1099,United States;United States;United States,Article,Boston;San Francisco;Boston,1,Journal,2-s2.0-0037125383
Vatten L.,,Insulin-like growth factor I and leptin in umbilical cord plasma and infant birth size at term,2002,Pediatrics,118,10.1542/peds.109.6.1131,Norway;Norway,Article,Stavanger;Trondheim,0,Journal,2-s2.0-0036266938
Hellawell G.O.,,Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease,2002,Cancer Research,307,,United Kingdom;United Kingdom,Article,Oxford;Oxford,0,Journal,2-s2.0-0037092971
Palmqvist R.,,"Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: A prospective study in northern Sweden",2002,Gut,181,10.1136/gut.50.5.642,France,Article,Lyon,1,Journal,2-s2.0-0036112482
Lopez T.,,Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis,2002,Cancer Cell,240,10.1016/S1535-6108(02)00055-7,United States,Article,San Francisco,1,Journal,2-s2.0-0036559535
Goodwin P.J.,,Fasting insulin and outcome in early-stage breast cancer: Results of a prospective cohort study,2002,Journal of Clinical Oncology,691,10.1200/JCO.20.1.42,Canada,Article,Toronto,0,Journal,2-s2.0-0036138579
Pollak M.,,Reduced mammary gland carcinogenesis in transgenic mice expressing a growth hormone antagonist,2001,British Journal of Cancer,102,10.1054/bjoc.2001.1895,Canada,Article,Montreal,1,Journal,2-s2.0-0035800512
Brogiolo W.,,An evolutionarily conserved function of the drosophila insulin receptor and insulin-like peptides in growth control,2001,Current Biology,796,10.1016/S0960-9822(01)00068-9,Switzerland,Article,Zurich,1,Journal,2-s2.0-0035916357
Mehta S.H.,,"Height, leg length, and cancer risk: A systematic review",2001,Epidemiologic Reviews,313,10.1093/oxfordjournals.epirev.a000809,United States,Review,Baltimore,1,Journal,2-s2.0-0035685665
Stattin P.,,"Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: A prospective study",2000,Journal of the National Cancer Institute,334,10.1093/jnci/92.23.1910,Sweden,Article,Umea,1,Journal,2-s2.0-0034614104
Byrne C.,,"Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density",2000,Cancer Research,226,,United States,Article,Boston,0,Journal,2-s2.0-0034660884
Giovannucci E.,,A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women,2000,Cancer Epidemiology Biomarkers and Prevention,352,,United States;United States;United States,Article,Boston;Boston;Boston,0,Journal,2-s2.0-0034019059
Harman S.,,"Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer",2000,Journal of Clinical Endocrinology and Metabolism,199,10.1210/jcem.85.11.6990,United States;United States,Article,Bethesda;Phoenix,1,Journal,2-s2.0-0034527640
Ma J.,,Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3,1999,Journal of the National Cancer Institute,968,10.1093/jnci/91.7.620,United States,Article,Boston,1,Journal,2-s2.0-0033531765
Rozen F.,,Antiproliferative action of vitamin D-related compounds and insulin- like growth factor-binding protein 5 accumulation,1997,Journal of the National Cancer Institute,86,10.1093/jnci/89.9.652,Canada,Article,Montreal,1,Journal,2-s2.0-0030957217
Gucev Z.S.,,Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor β2-induced growth inhibition in human breast cancer cells,1996,Cancer Research,233,,United States,Article,Portland,0,Journal,2-s2.0-0029975905
Huynh H.,,Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells,1996,Journal of Biological Chemistry,204,10.1074/jbc.271.2.1016,Canada,Article,Montreal,1,Journal,2-s2.0-0030067106
Buckbinder L.,,Induction of the growth inhibitor IGF-binding protein 3 by p53,1995,Nature,790,10.1038/377646a0,United States,Article,New York,0,Journal,2-s2.0-0028864667
Tibblin G.,,High birthweight as a predictor of prostate cancer risk,1995,Epidemiology,96,10.1097/00001648-199507000-00017,Sweden,Article,Uppsala,0,Journal,2-s2.0-0029072776
Souza A.,,M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity,1995,Nature Genetics,315,10.1038/ng1295-447,United Kingdom,Article,London,0,Journal,2-s2.0-0028804071
Sell C.,,Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor,1993,Proceedings of the National Academy of Sciences of the United States of America,524,10.1073/pnas.90.23.11217,United States,Article,Philadelphia,1,Journal,2-s2.0-0027366338
Pollak M.N.,,Presence of somatomedin receptors on primary human breast and colon carcinomas,1987,Cancer Letters,139,10.1016/0304-3835(87)90218-7,Canada;Canada,Article,Montreal;Montreal,0,Journal,2-s2.0-0023473304
Kritchevsky D.,,Influence of caloric intake on experimental carcinogenesis: a review.,1986,Advances in experimental medicine and biology,39,10.1007/978-1-4613-1835-4_7,,Review,,0,Journal,2-s2.0-0022828058
Ullrich A.,,Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity.,1986,The EMBO journal,1448,10.1002/j.1460-2075.1986.tb04528.x,,Article,,1,Journal,2-s2.0-0022800838
Steiner D.,,Structure and evolution of the insulin gene.,1985,Annual review of genetics,183,10.1146/annurev.ge.19.120185.002335,,Article,,0,Journal,2-s2.0-0022315366
Myal Y.,,Receptor Binding and Growth-promoting Activity of Insulin-like Growth Factors in Human Breast Cancer Cells (T-47D) in Culture,1984,Cancer Research,107,,Canada,Article,Winnipeg,0,Journal,2-s2.0-0021718287
Dull T.,,Insulin-like growth factor II precursor gene organization in relation to insulin gene family,1984,Nature,213,10.1038/310777a0,United States,Article,San Francisco,0,Journal,2-s2.0-0021222517
Jansen M.,,Sequence of cDNA encoding human insulin-like growth factor I precursor,1983,Nature,311,10.1038/306609a0,Netherlands,Article,Utrecht,0,Journal,2-s2.0-0021021639
Bell G.,,Sequence of the human insulin gene,1980,Nature,340,10.1038/284026a0,United States,Article,San Francisco,0,Journal,2-s2.0-0018887040
Ullrich A.,,Genetic variation in the human insulin gene,1980,Science,89,10.1126/science.6248962,United States,Article,San Francisco,0,Journal,2-s2.0-0019048070
Osborne C.,,Hormone responsive human breast cancer in long term tissue culture: effect of insulin,1976,Proceedings of the National Academy of Sciences of the United States of America,207,10.1073/pnas.73.12.4536,United States,Article,Bethesda,1,Journal,2-s2.0-0345447402
Heuson J.,,"Influence of Insulin Deprivation on Growth of the 7,12-Dimethylbenz(a)anthracene-induced Mammary Carcinoma in Rats Subjected to Alloxan Diabetes and Food Restriction",1972,Cancer Research,148,,Belgium,Article,Brussels,0,Journal,2-s2.0-0015296174
Heuson J.,,Cell proliferation induced by insulin in organ culture of rat mammary carcinoma,1967,Experimental Cell Research,46,10.1016/0014-4827(67)90185-1,Belgium,Article,Brussels,0,Journal,2-s2.0-0014056238
Elias J.,,Effect of Insulin and Cortisol on Organ Cultures of Adult Mouse Mammary Gland,1959,Proceedings of the Society for Experimental Biology and Medicine,45,10.3181/00379727-101-24995,United States;United States,Article,San Francisco;Berkeley,0,Journal,2-s2.0-0009573441
Salmon W.D.,,A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro,1957,The Journal of Laboratory and Clinical Medicine,908,,United States,Article,St. Louis,0,Journal,2-s2.0-0346206633
Weinhouse S.,,On respiratory impairment in cancer cells,1956,Science,389,10.1126/science.124.3215.267,United States,Article,Wynnewood,0,Journal,2-s2.0-11444255268
